ATH 25.0% 0.3¢ alterity therapeutics limited

Epi-Pen Scandal in America, page-7

  1. 1,847 Posts.
    lightbulb Created with Sketch. 1
    TB it is a little fishy that Teva wasn't allowed to bring a generic to the market (could be valid) paving the way for Mylan.
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.